These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 16215165)

  • 1. Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues.
    Thrailkill KM; Lumpkin CK; Bunn RC; Kemp SF; Fowlkes JL
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E735-45. PubMed ID: 16215165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of diabetes therapy on bone: A clinical perspective.
    Kheniser KG; Polanco Santos CM; Kashyap SR
    J Diabetes Complications; 2018 Jul; 32(7):713-719. PubMed ID: 29747995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of diabetes and its treatments on skeletal diseases.
    Yan W; Li X
    Front Med; 2013 Mar; 7(1):81-90. PubMed ID: 23377889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes Mellitus: Does it Affect Bone?
    Schwartz AV
    Calcif Tissue Int; 2003 Dec; 73(6):515-9. PubMed ID: 14517715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal Metabolism, Fracture Risk, and Fracture Outcomes in Type 1 and Type 2 Diabetes.
    Sellmeyer DE; Civitelli R; Hofbauer LC; Khosla S; Lecka-Czernik B; Schwartz AV
    Diabetes; 2016 Jul; 65(7):1757-66. PubMed ID: 27329951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of diabetes mellitus-induced bone fragility.
    Napoli N; Chandran M; Pierroz DD; Abrahamsen B; Schwartz AV; Ferrari SL;
    Nat Rev Endocrinol; 2017 Apr; 13(4):208-219. PubMed ID: 27658727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diabetic osteopathy].
    Ilić J; Kovacev B
    Med Pregl; 2005; 58(3-4):147-52. PubMed ID: 16526212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone health and multiple sclerosis.
    Dobson R; Ramagopalan S; Giovannoni G
    Mult Scler; 2012 Nov; 18(11):1522-8. PubMed ID: 22740489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MECHANISMS IN ENDOCRINOLOGY: Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus.
    Hough FS; Pierroz DD; Cooper C; Ferrari SL;
    Eur J Endocrinol; 2016 Apr; 174(4):R127-38. PubMed ID: 26537861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into bone fragility in diabetes: the crucial role of bone quality on skeletal strength.
    Yamamoto M
    Endocr J; 2015; 62(4):299-308. PubMed ID: 25797364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes mellitus a risk for osteoporosis?
    Leidig-Bruckner G; Ziegler R
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S493-514. PubMed ID: 11460594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone metabolism in diabetes: a clinician's guide to understanding the bone-glucose interplay.
    Sheu A; White CP; Center JR
    Diabetologia; 2024 Aug; 67(8):1493-1506. PubMed ID: 38761257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology and Management of Type 2 Diabetes Mellitus Bone Fragility.
    Eller-Vainicher C; Cairoli E; Grassi G; Grassi F; Catalano A; Merlotti D; Falchetti A; Gaudio A; Chiodini I; Gennari L
    J Diabetes Res; 2020; 2020():7608964. PubMed ID: 32566682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-analgesic effects of opioids: the interaction of opioids with bone and joints.
    Mattia C; Di Bussolo E; Coluzzi F
    Curr Pharm Des; 2012; 18(37):6005-9. PubMed ID: 22747537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoporosis and fractures in systemic lupus erythematosus.
    Bultink IE
    Arthritis Care Res (Hoboken); 2012 Jan; 64(1):2-8. PubMed ID: 22213721
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of endocrine disease: Diabetes and osteoporosis: cause for concern?
    Starup-Linde J; Vestergaard P
    Eur J Endocrinol; 2015 Sep; 173(3):R93-9. PubMed ID: 26243638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone health in type 1 diabetes: focus on evaluation and treatment in clinical practice.
    Zhukouskaya VV; Eller-Vainicher C; Shepelkevich AP; Dydyshko Y; Cairoli E; Chiodini I
    J Endocrinol Invest; 2015 Sep; 38(9):941-50. PubMed ID: 25863666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone, sweet bone--osteoporotic fractures in diabetes mellitus.
    Hamann C; Kirschner S; Günther KP; Hofbauer LC
    Nat Rev Endocrinol; 2012 Jan; 8(5):297-305. PubMed ID: 22249517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future studies using histomorphometry in type 1 diabetes mellitus.
    Graeff-Armas LA; Silverman E; Recker RR
    Curr Opin Endocrinol Diabetes Obes; 2021 Aug; 28(4):371-376. PubMed ID: 34183539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the pathology and mechanisms of type I diabetic bone loss.
    McCabe LR
    J Cell Biochem; 2007 Dec; 102(6):1343-57. PubMed ID: 17975793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.